Dr. Surya Sankuratri
Surya Sankuratri received his Ph.D. from the Indian Institute of Science and conducted his post-doctoral studies at Duke and Stanford Universities. He held R&D leadership positions at CV Therapeutics, Roche, Merck, and Gilead Sciences.
In the early part of his industry career, Surya led many drug discovery and development programs for many major therapy areas with unmet medical needs and contributed to several launched treatments. In the last 15 years, Surya led external innovation, in-, and out-licensing, M&A, and investment activities for Roche, Merck, and Gilead. He is currently the Head of Corporate Business Development at Atomwise, an AI-focused therapeutics R&D company. In addition, Surya serves as a science and business advisor and board member for several startups, established global biotech and investment companies, and philanthropic organizations.